Human Thrombin News
Human Thrombin currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Human Thrombin with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: TachoSil is indicated in adults and children from 1 month of age for supportive treatment in surgery for improvement of haemostasis, to promote tissue sealing and for suture support in vascular...
- Evidence level: L5
- Predicted indications (20):
- primary release disorder of platelets (97.0%)
- Glanzmann thrombasthenia (96.6%)
- pseudo-von Willebrand disease (96.5%)
- non-syndromic esophageal malformation (91.7%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (91.7%)
- bleeding diathesis due to a collagen receptor defect (91.5%)
- Scott syndrome (91.5%)
- esophageal disease (86.5%)
- fetal and neonatal alloimmune thrombocytopenia (86.2%)
- platelet-type bleeding disorder (86.1%)
- hemophilia (83.7%)
- hereditary thrombocytosis with transverse limb defect (83.7%)
- flood factor deficiency (83.6%)
- familial thrombomodulin anomalies (83.6%)
- acquired coagulation factor deficiency (83.5%)
- severe nonproliferative diabetic retinopathy (83.1%)
- thrombocytopenia due to immune destruction (83.1%)
- Ehlers-Danlos syndrome, fibronectinemic type (82.3%)
- congenital factor V deficiency (81.7%)
- neonatal thrombocytopenia (81.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.